Schedule 13G ownership disclosure

ADIAL PHARMACEUTICALS INC

Security class unavailable · CUSIP: 00688A106

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
676,126
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-20-000306
Form type
SC 13G/A
Filer
ADIAL PHARMACEUTICALS, INC.
CIK
CIK 1513525
Filed
Jan 21, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub